Medicines are a critical part of medical care. Their importance becomes particularly evident when the active ingredient required for treatment is not available. That is why we are working to give as many people as possible access to high quality, affordable and safe medicines. An essential prerequisite for this is the reliable availability of active ingredients.
Multi-sourcing: a clever procurement strategy for more security
At hameln pharma, we have specialized in the licensing and distribution of our generic injectables in recent years. Our goal: the reliable supply of medicines to as many people as possible. With the help of our multi-sourcing strategy with a focus on Europe, as well as the trusting and long-term cooperation with active ingredient and finished product manufacturers, we can guarantee consistent availability of our products.
We leave nothing to chance when it comes to the production of active ingredients
One of our main focuses is the supply of opioid analgesics – drugs that should always be available. For this reason, we have some key active ingredients such as sufentanil, alfentanil and remifentanil manufactured by our sister company, hameln rds s.r.o. in Slovakia.